NCT05390190
Radiofrequency in Onychomycosis
Non Ablative Radiofrequency in the Treatment of Onychomycosis, a Pilot Study
Cairo University·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Onychomycosis
- Drug/Device/Intervention
- Non ablative radiofrequency
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Cairo University
Timeline & enrollment
- Phase
- N/A
- Start date
- Jul 01, 2022
- End date
- Oct 01, 2022
- Enrollment
- 20 participants
Primary outcome
Onychomycosis severity index
Summary
Onychomycosis is the most common nail disease, representing more than 50% of all
 onychopathies.
ICD-10 classifications
OnychogryphosisChromomycosis, unspecifiedOnycholysisActinomycosisBlastomycosis
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05390190
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT05390190 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Not yet recruiting. The study focuses on Onychomycosis. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.